A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

Author： Abdul Razak A. R.   Soulires D.   Laurie S. A.   Hotte S. J.   Singh S.   Winquist E.   Chia S.   Le Tourneau C.   Nguyen-Tan P.- F.   Chen E. X.   Chan K. K.   Wang T.   Giri N.   Mormont C.   Quinn S.   Siu L. L.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 761-769

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Salvage Therapy with Oral Etoposide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By Gedlicka C.   Kornfehl J.   Turhani D.   Burian M.   Formanek M.  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 252-255

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E.   Moon James   Kuebler J. Philip   Nichols Craig R.   Gandara David R.   Ozer Howard   Williamson Stephen K.   Atkins James N.   Schuller David E.   Ensley John F.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group

By Benasso Marco   Ponzanelli Anna   Merlano Marco   Numico Gianmuro   Ricci Isabella   Vigo Viviana   Grossi Francesco   Amadori Dino   Cavallo Giovanna   Capaccetti Barbara   Taveggia Paola   Boni Luca   Rosso Riccardo  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 168-174

Informa Healthcare

Access to resources Recommend Favorite

Cost‐Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 225-233

John Wiley & Sons Inc

Access to resources Recommend Favorite